+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Peripheral Vascular Devices Market Report Suite - Europe - 2020-2026 - MedSuite

  • ID: 5028707
  • Report
  • April 2020
  • Region: Europe
  • iData Research

FEATURED COMPANIES

  • Aachen Resonance GmbH
  • Affluent Medical
  • Avinger
  • Blockade Medical
  • Cardiva
  • Endospan
  • MORE
Throughout this medical market research, the publisher analyzed 65 peripheral vascular companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the EU Peripheral Vascular Devices market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a peripheral vascular procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered
  • Procedure Numbers for the EU Peripheral Vascular Market– MedPro
  • Peripheral Arterial Stent Market - MedCore
  • Peripheral Venous Stent Market - MedCore
  • PTA Balloons Market - MedCore
  • Atherectomy Device Market - MedCore
  • CTO Market - MedCore
  • Embolic Protection Device Market - MedCore
  • Stent Grafts Market - MedCore
  • Surgical Stent Grafts Market - MedCore
  • AV Access Thrombectomy Device Market - MedCore
  • Inferior Vena Cava Filter Market - MedCore
  • Diagnostic and Interventional Catheter Market - MedCore
  • Diagnostic and Interventional Guidewire Market - MedCore
  • Introducer Sheaths Market - MedCore
  • Vascular Closure Device Market - MedCore
  • Transcatheter Embolization Device Market - MedCore
EU Peripheral Vascular Devices Market Insights

The growth of venous treatments in Europe is expected to accelerate in the coming years as clinical knowledge continues to develop and expertise in the medical community is diffused. While currently consolidated within select regions in the United Kingdom, Germany, France, Austria and Switzerland, venous treatment centers are expected to be developed across Europe to facilitate both the diagnosis and treatment of venous disease.

Treatment of peripheral arterial disease is slowly continuing to increase its penetration in the treatable population. As Europe continues to age, the total number of procedures is expected to grow over the forecast period. As reimbursement tensions continue, treatment techniques have continued to be refined towards the most cost effective, long-term option for patients.

Overall, the European peripheral vascular device market was valued at about €1.3 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.9% to reach about €1.6 billion.

Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Scandinavia (Denmark, Finland, Norway, and Sweden)
  • Switzerland
  • Austria
  • Portugal
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aachen Resonance GmbH
  • Affluent Medical
  • Avinger
  • Blockade Medical
  • Cardiva
  • Endospan
  • MORE
  • TABLE OF CONTENTS
  • LIST OF FIGURES
  • LIST OF CHARTS
  • EXECUTIVE SUMMARY

1. EUROPEAN MARKET FOR PERIPHERAL VASCULAR DEVICES OVERVIEW

  • COMPETITIVE ANALYSIS
  • MARKET TRENDS
  • MARKET DEVELOPMENTS
  • PROCEDURE NUMBERS
  • MARKETS INCLUDED
  • VERSION HISTORY
  • RESEARCH METHODOLOGY
  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS & DIAGNOSTICS
2.2.1 Aortic Aneurysms
2.2.2 Atherosclerosis
2.2.3 Peripheral Arterial Disease (PAD)
2.2.4 Deep Vein Thrombosis (DVT)
2.2.5 Pulmonary Embolism (PE)
2.3 PATIENT DEMOGRAPHICS
2.3.1 Aortic Aneurysms
2.3.2 Atherosclerosis
2.3.3 Peripheral Arterial Disease (PAD)
2.3.4 Deep Vein Thrombosis (DVT)
2.3.5 Pulmonary Embolism (PE)

3. PRODUCT PORTFOLIO
3.1 INTRODUCTION
3.2 PRODUCT PORTFOLIOS
3.2.1 Peripheral Vascular Stent
3.2.2 Venous Stent
3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon
3.2.4 Drug-Coated Balloon
3.2.5 Atherectomy Device
3.2.6 Chronic Total Occlusion (CTO) Device
3.2.7 Intravascular Lithotripsy
3.2.8 Surgical Graft
3.2.9 Stent Graft
3.2.10 Embolic Protection Device
3.2.11 Peripheral Thrombus Management Device
3.2.12 Inferior Vena Cava Filter
3.2.13 Carotid Shunt
3.2.14 Diagnostic and Interventional Catheters
3.2.15 Diagnostic and Interventional Guidewire
3.2.16 Introducer Sheath
3.2.17 Vascular Closure Device (VCD)
3.2.18 Transcatheter Embolization Device
3.2.19 Peripheral IVUS Catheter
3.3 REGULATORY ISSUES AND RECALLS
3.3.1 Abbott
3.3.1.1 Carotid Shunt
3.3.1.2 Vascular Closure Device
3.3.2 Argon Medical
3.3.2.1 Introducer Sheaths
3.3.3 Arrow International
3.3.3.1 Introducer Sheaths
3.3.4 Atrium Medical
3.3.4.1 Peripheral Vascular Stent
3.3.5 BD
3.3.5.1 Inferior Vena Cava Filter
3.3.5.2 Introducer Sheaths
3.3.5.3 Stent Graft
3.3.6 Boston Scientific
3.3.6.1 Atherectomy Devices
3.3.6.2 Diagnostic and Interventional Catheters
3.3.6.3 Introducer Sheaths
3.3.6.4 Peripheral Thrombus Management Devices
3.3.7 Cardinal Health
3.3.7.1 Vascular Closure Devices
3.3.8 Cardiovascular System (C.S.I.)
3.3.8.1 Atherectomy Devices
3.3.9 Cook Medical
3.3.9.1 Diagnostic and Interventional Catheters
3.3.9.2 Introducer Sheaths
3.3.9.3 Inferior Vena Cava Filters
3.3.9.4 Peripheral Vascular Stents
3.3.9.5 Stent Grafts
3.3.10 Cordis (Cardinal Health)
3.3.10.1 Diagnostic and Interventional Catheters
3.3.10.2 Inferior Vena Cava Filters
3.3.10.3 Peripheral Stents
3.3.11 Endologix
3.3.11.1 Stent Grafts
3.3.12 Edwards Lifesciences
3.3.12.1 Chronic Total Occlusion Devices
3.3.13 Maquet
3.3.13.1 PTA Balloons
3.3.14 Medtronic
3.3.14.1 Carotid Shunts
3.3.14.2 Diagnostic and Interventional Catheters
3.3.14.3 PTA Balloon Catheters
3.3.14.4 Peripheral Stents
3.3.14.5 Stent Grafts
3.3.14.6 Transcatheter Embolization Devices
3.3.15 Spectranetics (Philips)
3.3.15.1 Atherectomy Devices
3.3.15.2 Chronic Total Occlusion Devices
3.3.16 Shockwave Medical, Inc.
3.3.16.1 Intravascular Lithotripsy
3.3.17 Terumo
3.3.17.1 Introducer Sheaths
3.3.17.2 PTA Balloon Catheters
3.3.18 Other Companies
3.3.18.1 Atherectomy Devices
3.3.18.2 Introducer Sheaths
3.3.18.3 PTA Balloon Catheters
3.3.18.4 Peripheral IVUS Catheters
3.3.18.5 Stent Grafts
3.3.18.6 Vascular Closure Devices (VCD)
3.4 CLINICAL TRIALS
3.4.1 Abbott
3.4.1.1 Peripheral Vascular Stent
3.4.1.2 Other Peripheral Vascular Related Studies
3.4.2 B. Braun
3.4.2.1 Diagnostic and Interventional Catheters
3.4.2.2 Peripheral Vascular Stent
3.4.3 Boston Scientific
3.4.3.1 Atherectomy Devices
3.4.3.2 Drug-Coated Balloons
3.4.3.3 Peripheral Vascular Stents
3.4.3.4 Other Peripheral Vascular Related Studies
3.4.3.5 Venous Stents
3.4.4 C.R. Bard (BD)
3.4.4.1 Diagnostic and Interventional Catheters
3.4.4.2 Drug-Coated Balloons
3.4.4.3 Venous Stents
3.4.4.4 Other Peripheral Vascular Related Studies
3.4.5 Cardinal Health
3.4.5.1 Other Peripheral Vascular Related Studies
3.4.6 Cook Medical
3.4.6.1 Drug-Eluting Stents
3.4.6.2 Inferior Vena Cava Filters
3.4.6.3 Peripheral Vascular Stents
3.4.6.4 Venous Stents
3.4.7 Cordis (Cardinal Health)
3.4.7.1 Peripheral Vascular Stents
3.4.8 Medtronic
3.4.8.1 Atherectomy Devices
3.4.8.2 Drug-Coated Balloons
3.4.8.3 Other Peripheral Vascular Related Studies
3.4.9 Merit Medical
3.4.9.1 Stent Grafts
3.4.10 Philips/Spectranetics
3.4.10.1 Atherectomy Devices
3.4.10.2 Peripheral IVUS Catheters
3.4.10.3 Spectranetics
3.4.10.3.1 Drug-Coated Balloons
3.4.10.3.2 Atherectomy Devices
3.4.11 Shockwave Medical, Inc.
3.4.11.1 Lithoplasty System
3.4.12 Surmodics
3.4.12.1 Drug-Coated Balloons
3.4.13 Terumo
3.4.13.1 Drug-Coated Balloons
3.4.13.2 Peripheral Vascular Stents
3.4.14 W.L. Gore
3.4.14.1 Peripheral Vascular Stents
3.4.14.2 Stent Grafts
3.4.14.3 Expandable Balloons
3.4.15 Other Companies
3.4.15.1 Carotid Shunt / Endarterectomy
3.4.15.2 Drug-Coated Balloons
3.4.15.3 Peripheral Vascular Stents
3.4.15.4 Other Peripheral Vascular Related Studies

4. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW
4.1 INTRODUCTION
4.1.1 Atherosclerosis
4.1.2 Peripheral Arterial Disease (PAD)
4.2 CURRENCY EXCHANGE RATE
4.3 MARKET OVERVIEW
4.4 TREND ANALYSIS
4.5 DRIVERS AND LIMITERS
4.5.1 Market Drivers
4.5.2 Market Limiters
4.6 COMPETITIVE MARKET SHARE ANALYSIS
4.7 COMPANY PROFILES
4.7.1 Abbott
4.7.2 Becton Dickinson (BD)
4.7.3 Boston Scientific
4.7.4 Cardinal Health
4.7.4.1 Cordis (Cardinal Health)
4.7.5 Cook Medical
4.7.6 Maquet
4.7.7 Medtronic
4.7.8 Teleflex
4.7.9 Terumo Interventional System (TIS)
4.7.10 W.L. Gore
4.8 SWOT ANALYSIS
4.8.1 Abbott
4.8.2 B. Braun
4.8.3 Boston Scientific
4.8.4 BD
4.8.5 Cardinal Health
4.8.6 Cook Medical
4.8.7 Integra Lifesciences
4.8.8 Maquet
4.8.9 Medtronic
4.8.10 Merit Medical
4.8.11 Phillips
4.8.12 Teleflex
4.8.13 Terumo
4.8.14 W.L. Gore
4.9 MERGERS AND ACQUISITIONS

5. COUNTRY PROFILES
5.1 INTRODUCTION
5.1.1.1 Population
5.1.1.2 Median Age
5.1.1.3 GDP Per Capita
5.1.1.4 Price Index
5.2 GERMANY
5.3 FRANCE
5.4 UNITED KINGDOM
5.5 ITALY
5.6 SPAIN
5.7 BENELUX
5.8 SCANDINAVIA
5.9 AUSTRIA
5.10 SWITZERLAND
5.11 PORTUGAL

6. PROCEDURE NUMBERS
6.1 PROCEDURES
6.1.1 Total Procedures
6.1.2 Bare Metal Stent Procedures
6.1.2.1 Iliac Bare Metal Stent Procedures
6.1.2.2 Femoral Popliteal Bare Metal Stent Procedures
6.1.2.3 Infra-Popliteal Bare Metal Stent Procedures
6.1.2.4 Renal Bare Metal Stent Procedures
6.1.2.5 Carotid Bare Metal Stent Procedures
6.1.3 Venous Stenting Procedures
6.1.4 Angioplasty Procedures
6.1.5 Atherectomy Procedures
6.1.6 Chronic Total Occlusion Procedures
6.1.7 Embolic Protection Device Procedures
6.1.8 Stent Graft Procedures
6.1.8.1 AAA Stent Graft Procedures
6.1.8.2 TAA Stent Graft Procedures
6.1.8.3 Fenestrated Stent Graft Procedures
6.1.9 Surgical Graft Procedures
6.1.9.1 Lower Limb Surgical Graft Procedures
6.1.9.2 AV Access Surgical Graft Procedures
6.1.9.3 Aorta Repair Surgical Graft Procedures
6.1.9.3.1 AAA Surgical Graft Procedures
6.1.9.3.2 TAA Surgical Graft Procedures
6.1.9.4 Extra-Anatomical Surgical Graft Procedures
6.1.10 AV Access Thrombectomy Procedures

Note: Product cover images may vary from those shown
  • Aachen Resonance GmbH
  • Boston Scientific
  • Abbott Vascular
  • C. R. Bard
  • Acandis GmbH
  • Cardinal Health
  • ACIST Medical
  • Cardionovum GmbH
  • Acrostak
  • Cardiovascular Systems Inc.
  • Affluent Medical
  • Cardiva
  • AngioDynamics
  • Celenova Biosciences Inc
  • Argon Medical
  • Concept Medical
  • Asahi Intecc
  • Contego Medical
  • Avimedica
  • Control Medical Technology
  • Avinger
  • Cook Medical
  • B. Braun
  • Endospan
  • BiO2
  • Eurocor
  • Biosensors International Group Ltd.
  • Infraredx Inc.
  • Biotronik
  • InSeal Medical
  • Biovic
  • Invamed
  • Blockade Medical
  • Jotec
Note: Product cover images may vary from those shown
Adroll
adroll